These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 15340365)

  • 1. The geography of HFE mutations: molecular diagnosis of haemochromatosis and the globalization of genetic testing.
    Salto-Tellez M; Siew-Chuan Koay E
    Eur J Hum Genet; 2004 Nov; 12(11):877-8. PubMed ID: 15340365
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevalence of C282Y, H63D and S65C mutations of the hemochromatosis (HFE) gene in a population from southeastern Spain (Murcia Region).
    Muro M; Moya-Quiles MR; Botella C; Alvarez-López MR
    Clin Genet; 2007 Jan; 71(1):97-8. PubMed ID: 17204056
    [No Abstract]   [Full Text] [Related]  

  • 3. Polymorphism in intron 4 of HFE does not compromise haemochromatosis mutation results. The European Haemochromatosis Consortium.
    Merryweather-Clarke AT; Pointon JJ; Shearman JD; Robson KJ; Jouanolle AM; Mosser A; David V; Le Gall JY; Halsall DJ; Elsey TS; Kelly A; Cox TM; Clare M; Bomford A; Vandwalle JL; Rochette J; Borot N; Coppin H; Roth MP; Ryan E; Crowe J; Totaro A; Gasparini P; Roetto A; Walker AP
    Nat Genet; 1999 Nov; 23(3):271. PubMed ID: 10545942
    [No Abstract]   [Full Text] [Related]  

  • 4. [Diagnosis and treatment of genetic haemochromatosis].
    Milman NT
    Ugeskr Laeger; 2013 Apr; 175(16):1109-12. PubMed ID: 23651749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [From gene to disease; HFE-mutations in primary haemochromatosis].
    Swinkels DW; Jacobs EM
    Ned Tijdschr Geneeskd; 2003 Apr; 147(14):652-6. PubMed ID: 12712648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemochromatosis: diagnosis and management after the cloning of the HFE gene.
    Powell LW; Bassett ML
    Aust N Z J Med; 1998 Apr; 28(2):159-63. PubMed ID: 9612522
    [No Abstract]   [Full Text] [Related]  

  • 7. No age-related decrease in frequency of heterozygotes for the HFE C282Y haemochromatosis mutation.
    Waalen J; Beutler E
    J Hepatol; 2004 Jun; 40(6):1044; author reply 1044-5. PubMed ID: 15158353
    [No Abstract]   [Full Text] [Related]  

  • 8. Gene symbol: HFE. Disease: Haemochromatosis.
    Bento MC; Ribeiro ML; Relvas L
    Hum Genet; 2004 Mar; 114(4):405. PubMed ID: 15046077
    [No Abstract]   [Full Text] [Related]  

  • 9. Polymorphism in intron 4 of HFE does not compromise haemochromatosis mutation results.
    Noll WW; Belloni DR; Stenzel TT; Grody WW
    Nat Genet; 1999 Nov; 23(3):271-2. PubMed ID: 10610176
    [No Abstract]   [Full Text] [Related]  

  • 10. Human gene mutations. Gene symbol: HFE. Disease: hereditary haemochromatosis.
    de Villiers JN; Scholtz CL; Hoogendijk CF; Cawood EJ; Kotze MJ
    Hum Genet; 1998 Jan; 102(1):127. PubMed ID: 9490291
    [No Abstract]   [Full Text] [Related]  

  • 11. Polymorphism in intron 4 of HFE does not compromise haemochromatosis mutation results.
    Gomez PS; Parks S; Ries R; Tran TC; Gomez PF; Press RD
    Nat Genet; 1999 Nov; 23(3):272. PubMed ID: 10545944
    [No Abstract]   [Full Text] [Related]  

  • 12. [Frequency of HFE gene mutations and genotype-phenotype correlations in patients with hereditary hemochromatosis in Switzerland].
    Himmelmann A; Bortoluzzi L; Jansen S; Fehr J
    Schweiz Med Wochenschr; 2000 Aug; 130(31-32):1112-9. PubMed ID: 11008304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of HFE genetic testing on clinical presentation of hereditary hemochromatosis: new epidemiological data.
    Scotet V; Le Gac G; Mérour MC; Mercier AY; Chanu B; Ka C; Mura C; Nousbaum JB; Férec C
    BMC Med Genet; 2005 Jun; 6():24. PubMed ID: 15929798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical usefulness of the detection of mutations of the HFE gene in hemochromatosis].
    Oliva R; Sánchez M; Bruguera M; Rodés J
    Gastroenterol Hepatol; 2000 Nov; 23(9):433-5. PubMed ID: 11126040
    [No Abstract]   [Full Text] [Related]  

  • 15. Best practice guidelines for the molecular genetic diagnosis of Type 1 (HFE-related) hereditary haemochromatosis.
    King C; Barton DE
    BMC Med Genet; 2006 Nov; 7():81. PubMed ID: 17134494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The origin and spread of the HFE-C282Y haemochromatosis mutation.
    Distante S; Robson KJ; Graham-Campbell J; Arnaiz-Villena A; Brissot P; Worwood M
    Hum Genet; 2004 Sep; 115(4):269-79. PubMed ID: 15290237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Genetic hemochromatosis and the HFE gene].
    Moirand R
    Bull Acad Natl Med; 2000; 184(2):325-35; discussion 335-6. PubMed ID: 10989541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemochromatosis, HFE and genetic complexity.
    Risch N
    Nat Genet; 1997 Dec; 17(4):375-6. PubMed ID: 9398831
    [No Abstract]   [Full Text] [Related]  

  • 19. Characterization of the second HFE gross deletion highlights the potential importance of Alu-mediated recombination in haemochromatosis.
    Ka C; Chen JM; Gourlaouen I; Quemener S; Ronsin C; Massonnet S; Thérond JP; Férec C; Le Gac G
    Br J Haematol; 2015 Mar; 168(5):759-62. PubMed ID: 25284364
    [No Abstract]   [Full Text] [Related]  

  • 20. Presence of the hemochromatosis S65C mutation leads to failure of amplification in a multiplex C282Y/H63D PCR.
    Koeken A; de Baar E; Schrauwen L; Cobbaert C
    Clin Chem; 2007 Sep; 53(9):1715. PubMed ID: 17712010
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.